GEN-MKT-18-7897-A
Jul 1, 2019 | Blogs, Clinical | 0 comments
Steven Wong, Ph.D., DABCC (TC), FACB, Past President AACC, Professor of Pathology, serves as Director of the Clinical Chemistry and Toxicology Core Laboratory and is Co-director of the Clinical and Translational Mass Spectrometry Center at Wake Forest School of Medicine with over 37 years of experience.
Elizabeth Palavecino, MD, serves as Medical Director of Clinical Microbiology and is Co-director of the Clinical and Translational Mass Spectrometry Center at Wake Forest School of Medicine.
Q: Please share details about your institution.
Wake Forest Baptist Medical Center is a nationally prominent academic medical center in Winston-Salem, NC, with an integrated health care network. The Health System includes an 800+ bed hospital serving both an adult and pediatric population with many specialty centers including Cancer and Transplant.
Q: What are your key translational research areas and goals?
We created this translational research unit to look at ways to create new tests for clinical purposes. For example, we have a large population of immunosuppressed patients, so we need a way of testing immunosuppressants or antifungal panels in a rapid way, but also in a very accurate and reliable way. That’s why we started developing these tests using mass spectrometry. Additional focus areas include acute kidney injury, drug toxicity, breast cancer, renal metabolomics, and personalized medicine approaches.
Q: How has implementing mass spectrometry helped allow your institution to provide the best patient care?
Mass spectrometry is no longer confined to the research lab but is becoming part of the routine testing in clinical labs. It was really a clinical necessity for our lab. Mass spectrometry can give me the answer reliably because it is very specific and only requires a very small volume. By bringing the test in house, the turnaround time improved drastically, from 3-4 days to 8-24 hours. That really helped improve patient care.
Q: Why is the SCIEX Citrine™ MS/MS system the right tool to further your diagnostic work?
First is the performance of the mass spec. It has higher sensitivity and is more flexible. Because we are getting it from the same source, it allowed us to establish redundancy in our testing with the two existing mass spec. The enhanced sensitivity allowed us to engage in low-level toxicology testing. The most infamous example right now is fentanyl which is a very potent drug in low concentration. The sensitivity of the newer mass spec allowed us to do an adequate detection of a very highly potent drug like fentanyl.
We have also had extremely positive interactions with both the support service teams within SCIEX as well as the quick response to our needs and are very pleased with that.Learn More About SCIEX Systems >
Produced by certain moulds, thriving in crops such as grain, nuts and coffee, mycotoxins have contaminated agriculture and food production industries for a long time. To intensify the challenge, mycotoxins are resilient, not easily broken down and ensuring the safety of food supply chains requires comprehensive solutions and we are here to share those solutions with you.
Electron-Activated Dissociation (EAD) is transforming the fields of metabolomics and lipidomics by providing enhanced fragmentation techniques that offer deeper insights into molecular structures. In September, Technology Networks hosted a webinar, “Enhancing Mass-Based Omics Analysis in Model Organisms,” featuring Dr. Valentina Calabrese from the Institute of Analytical Sciences at the University of Lyon. Valentina shared her insights on improving omics-based mass spectrometry analysis for toxicology studies using model organisms, particularly in metabolomics and lipidomics. This blog explores the additional functionalities EAD offers, its benefits in untargeted workflows, its incorporation into GNPS and molecular networking, and the future role it could play in these scientific domains.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has gained significant attention in the clinical laboratory due to its ability to provide best-in-class sensitivity and specificity for the detection of clinically relevant analytes across a wide range of assays. For clinical laboratories new to LC-MS/MS, integrating this technology into their daily routine operations may seem like a daunting task. Developing a clear outline and defining the requirements needed to implement LC-MS/MS into your daily operations is critical to maximize the productivity and success of your clinical laboratory.
Posted by
You must be logged in to post a comment.
Share this post with your network